Patents/Assignees

CRINETICS PHARMACEUTICALS, Inc.

14 patents in portfolio

US12617767utility2026
Crystalline Forms of Somatostatin Modulators
0 cites
US12600709utility2026
Nonpeptide Somatostatin Type 5 Receptor Agonists and Uses Thereof
0 cites
US12492181utility2025
Gem-disubstituted Piperidine Melanocortin Subtype-2 Receptor (MC2R) Antagonists and Uses Thereof
0 cites
US12479825utility2025
Melanocortin Subtype-2 Receptor (MC2R) Antagonists and Uses Thereof
0 cites
US12479828utility2025
Melanocortin Subtype-2 Receptor (MC2R) Antagonists and Uses Thereof
0 cites
US12466829utility2025
Spirocyclic Piperidine Melanocortin Subtype-2 Receptor (MC2R) Antagonists and Uses Thereof
0 cites
US12280046utility2025
Melanocortin Subtype-2 Receptor (MC2R) Antagonist for the Treatment of Disease
0 cites
US12208092utility2025
Compositions and Methods for Administering Paltusotine to Patients with Hepatic Impairment
0 cites
US12134610utility2024
Somatostatin Subtype-2 Receptor (SST2R) Targeted Therapeutics and Uses Thereof
0 cites
US11957674utility2024
Formulations of a Somatostatin Modulator
0 cites
US11834462utility2023
Somatostatin Modulators and Uses Thereof
0 cites
US11773076utility2023
Crystalline Forms of a Somatostatin Modulator
0 cites
US11608335utility2023
Somatostatin Modulators and Uses Thereof
0 cites
US11566015utility2023
Melanocortin Subtype-2 Receptor (MC2R) Antagonists and Uses Thereof
0 cites